Stocks With Rising Relative Strength: ResMed

ResMed (RMD) saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 70 to 79.

When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.

This proprietary rating measures market leadership by showing how a stock’s price action over the last 52 weeks measures up against that of the other stocks in our database.

History reveals that the stocks that go on to make the biggest gains typically have an 80 or higher RS Rating in the early stages of their moves. See if ResMed can continue to rebound and hit that benchmark.

See How IBD Helps You Make More Money In Stocks

ResMed is trying to complete a double bottom with a 262.48 entry. See if the stock can clear the breakout price in heavy trade.

EPS growth decreased last quarter from 10% to 0%, but the top line rose from 4% to 5%.

The company earns the No. 6 rank among its peers in the Medical-Products industry group. Zynex (ZYXI) and Abiomed (ABMD) are also among the group’s highest-rated stocks.


Which Stocks Are Showing Improved Price Performance?

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Find Top Stocks Near A Buy Point With IBD Leaderboard

Most Related Links :
UK Prime News Latest News Sports News Finance News Automobile News

Root link

Related Articles

Back to top button